XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Clinical Infectious Diseases

MRSA Channel
subscribe to MRSA newsletter

Latest Research : Infectious Diseases : MRSA

   DISCUSS   |   EMAIL   |   PRINT
Study shows rising incidence of CA-MRSA muscle infections
Sep 7, 2006 - 12:33:00 AM, Reviewed by: Dr. Rashmi Yadav

"Physicians need to be aware that this is a possibility and consider initial treatment with an antibiotic that covers MRSA, particularly if they live in a region where methicillin resistance is present."

 
Researchers in Houston, Texas have found two bacterial muscle infections common in tropical countries becoming more frequent occurrences along with the emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), according to a study published in the Oct. 15 issue of Clinical Infectious Diseases, now available online.

Staphylococcus aureus, or staph, is a common bacterium found on the skin or in the nose of a quarter to a third of all people. Usually harmless, staph can cause skin infections such as pimples and boils and, less frequently, serious infections of surgical wounds or the bloodstream, and pneumonia. For years, infections caused by Staphylococcus aureus have been treated by inexpensive antibiotics in the penicillin and cephalosporin family.

Some years ago, strains resistant to these drugs, called methicillin-resistant Staphylococcus aureus (MRSA) appeared in hospitalized patients. Recently, however, newer forms of MRSA began to strike healthy people who have not been recently hospitalized or undergone invasive medical procedures. These community-acquired strains appear to be readily transmitted from person to person and can cause serious skin and soft tissue infections as well as invasive infections such as bone or joint infections or pneumonia. Failure by physicians to suspect this kind of drug-resistant staph can lead to treatment with the wrong antibiotic.

Pyomyositis is an acute bacterial infection of skeletal muscle that produces an abscess within the muscle. Myositis is also a muscle infection, but does not form an abscess. The study authors investigated the 45 cases of pyomyositis or myositis in otherwise healthy children who were hospitalized at Texas Children's Hospital from 2000 through 2005. Sixteen of these cases were caused by CA-MRSA and 10 by CA-MSSA (methicillin-susceptible Staphylococcus aureus).

The number of cases increased year by year, from four cases in the first year of the study to a high of 12 cases in the fifth year of the study. The authors also discovered that a specific strain of Staphylococcus aureus known as USA300 was associated with more severe disease. Similarly, staph that carried a group of genes known as PVL were also linked to a more severe illness.

"We're seeing an increasing number of muscle infections that is clearly associated with an increase in MRSA," said lead author Pia Pannaraj, MD. "Physicians need to be aware that this is a possibility and consider initial treatment with an antibiotic that covers MRSA, particularly if they live in a region where methicillin resistance is present."
 

- The study is published in the Oct. 15 issue of Clinical Infectious Diseases.
 

 
Subscribe to MRSA Newsletter
E-mail Address:

 

Founded in 1979, Clinical Infectious Diseases publishes clinical articles twice monthly in a variety of areas of infectious disease, and is one of the most highly regarded journals in this specialty. It is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Alexandria, Virginia, IDSA is a professional society representing about 8,000 physicians and scientists who specialize in infectious diseases. For more information, visit www.idsociety.org.

Related MRSA News

Transmission of MRSA Linked to Previous Intensive Care Unit Room Occupants
Study shows rising incidence of CA-MRSA muscle infections
Acanthamoeba polyphagam acts as an incubator for MRSA
MRSA infects and replicates in amoebae
Two Million Americans Harbor MRSA Superbug
25% Of Hospital MRSA Bacteraemia Occurs In New Arrivals
Zyvox� More Effective than Vancomycin in Treating Complicated Soft Tissue Infections
Patent Issued for Dalbavancin for the Treatment of Complicated Skin and Soft Tissue Infections
Community MRSA is re-emergence of 1950's pandemic
Drug-Resistant MRSA a Growing Threat


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us